MGX
Metagenomi, Inc. Common Stock
NASDAQ · USHealthcareBiotechnology
$1.24+0.00%
Price as of Jul 20, 2026
MGX earnings
Metagenomi, Inc. Common Stock earnings
Reported EPS and revenue history, upcoming estimates and available earnings-call summaries.
Next earnings
Aug 11, 2026in NaN days
EPS est $-0.55 · Revenue est $3M
Track record
Beat EPS in 5 of 8 quarters
Avg surprise +7.1% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| May 11, 2026 | $-0.60 | $-0.61 | -1.7% | $1M | -78.9% |
| Mar 5, 2026 | $-0.61 | $-0.60 | +1.0% | $4M | -46.6% |
| Nov 11, 2025 | $-0.60 | $-0.55 | +8.3% | $9M | +10.7% |
| Aug 12, 2025 | $-0.68 | $-0.54 | +20.6% | $9M | +7.2% |
| Mar 17, 2025 | $-0.62 | $-0.63 | -1.6% | $10M | +4.1% |
| Nov 13, 2024 | $-0.70 | $-0.45 | +35.7% | $12M | +70.3% |
| Aug 14, 2024 | $-0.59 | $-0.29 | +50.8% | $20M | +58.2% |
| Feb 10, 2024 | $-2.04 | $-0.51 | +74.8% | $12M | +6.9% |
| Jun 30, 2022 | — | $-1.57 | — | $3M | — |
| Mar 31, 2022 | — | $-1.57 | — | $3M | — |
Earnings history is derived from company filings and calendar data. Call summaries are grouped by reporting period. Latest covered event: 2026-08-11.